Merck and Moderna Release Landmark Personalized Cancer Therapy Trial Success, Stocks Soar...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Why Apple Is the Blueprint for SK Hynix's AI Cash Mountain...
Merck shares are trading higher after the company announced topline results from the Phase 3 INTerpath-001 trial. The trial met its primary and key se...
3 Sectors Investors Should Buy Now as S&P 500 Stumbles — Strategist Sees 15%-18% Upside...
Honeywell Technologies Appoints Billal Hammoud President, CEO Of Process Technology, Juan Picon President, CEO Of Building Automation, Effective Oct. ...
Argus Research Maintains Buy on Amgen, Raises Price Target to $460...
Guggenheim Reiterates Buy on Home Depot, Maintains $425 Price Target...
Amazon Bets Big on Drone Delivery — Prime Air Targets 500 US Cities as Competition From Wing, Zipline Heats Up...
Taiwan Semiconductor’s AI Bottleneck Hands Samsung a Powerful Pricing Opportunity...
RBC Capital Maintains Sector Perform on Home Depot, Lowers Price Target to $342...
Estee Lauder, Moderna, Merck And Other Big Stocks Moving Higher On Wednesday...
Argus Research Reiterates Buy on Home Depot, Maintains $400 Price Target...
Stock of the Day: Is Walmart Setting up to Rally Ahead of its Earnings?...
Keybanc Reiterates Sector Weight on Home Depotto Sector Weight...
Replit Rolling Out GPT-5.6 Luna-Powered Free Mode...
Truist Securities Maintains Buy on Home Depot, Raises Price Target to $373...
Alphabet Raises $3.9B in First Australian Bond Sale as AI Spending Surges...
Amgen shares are trading higher after Argus Research raised its price target on the stock from $375 to $460....
EVP At Johnson & Johnson Exercises Options Worth $2.38M...
These Analysts Revise Their Forecasts On Home Depot After Q2 Earnings...